Role of miRNA‑145‑5p in cancer (Review)
- Authors:
- Zeshan Chen
- Yijue Qin
-
Affiliations: Department of Traditional Chinese Medicine, Guangxi Zhuang Autonomous Region People's Hospital, Nanning, Guangxi 530016, P.R. China - Published online on: January 30, 2025 https://doi.org/10.3892/or.2025.8872
- Article Number: 39
-
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
|
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 74:229–263. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang T, Hu Y, Yang N, Yu S and Pu X: The microRNA-34 family and its functional role in lung cancer. Am J Clin Oncol. 47:448–457. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Morales-Martínez M and Vega MI: Role of MicroRNA-7 (MiR-7) in cancer physiopathology. Int J Mol Sci. 23:90912022. View Article : Google Scholar : PubMed/NCBI | |
|
Saikia M, Paul S and Chakraborty S: Role of microRNA in forming breast carcinoma. Life Sci. 259:1182562020. View Article : Google Scholar : PubMed/NCBI | |
|
Roufayel R and Kadry S. MicroRNAs: Crucial regulators of stress. Microrna. 9:93–100. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Kwok ZH, Zhang B, Chew XH, Chan JJ, Teh V, Yang H, Kappei D and Tay Y: Systematic analysis of intronic mirnas reveals cooperativity within the multicomponent FTX locus to promote colon cancer development. Cancer Res. 81:1308–1320. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Sun J, Deng L and Gong Y: MiR-145-5p inhibits the invasion of prostate cancer and induces apoptosis by inhibiting WIP1. J Oncol. 2021:44127052021. View Article : Google Scholar : PubMed/NCBI | |
|
Chang WW, Wang BY, Chen SH, Chien PJ, Sheu GT and Lin CH: miR-145-5p targets Sp1 in non-small cell lung cancer cells and links to BMI1 induced pemetrexed resistance and epithelial-mesenchymal transition. Int J Mol Sci. 23:153522022. View Article : Google Scholar : PubMed/NCBI | |
|
Bai HX, Qiu XM, Xu CH and Guo JQ: MiRNA-145-5p inhibits gastric cancer progression via the serpin family E member 1-extracellular signal-regulated kinase-1/2 axis. World J Gastrointest Oncol. 16:2123–2140. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Bellissimo T, Tito C, Ganci F, Sacconi A, Masciarelli S, Di Martino G, Porta N, Cirenza M, Sorci M, De Angelis L, et al: Argonaute 2 drives miR-145-5p-dependent gene expression program in breast cancer cells. Cell Death Dis. 10:172019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Z, Liu W, Huang T, Li J, Hu H, Xu X and Fan Z: CircCPA4 induces ASCT2 expression to promote tumor property of non-small cell lung cancer cells in a miR-145-5p-dependent manner. Thorac Cancer. 15:764–777. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Chu DX, Jin Y, Wang BR, Jiao Y, Zhang CK, Guo ZH, Hu SZ and Li N: LncRNA HOTAIR enhances epithelial-to-mesenchymal transition to promote the migration and invasion of liver cancer by regulating NUAK1 via epigenetic inhibition miR-145-5p expression. J Cancer. 14:2329–2343. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Di Agostino S, Canu V, Donzelli S, Pulito C, Sacconi A, Ganci F, Valenti F, Goeman F, Scalera S, Rollo F, et al: HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis. Cell Death Dis. 14:5352023. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang L, Wang X, Li Y, Han J, Gao X, Li S and Wang F: c-Myb facilitates immune escape of esophageal adenocarcinoma cells through the miR-145-5p/SPOP/PD-L1 axis. Clin Transl Med. 11:e4642021. View Article : Google Scholar : PubMed/NCBI | |
|
Donzelli S, Mori F, Bellissimo T, Sacconi A, Casini B, Frixa T, Roscilli G, Aurisicchio L, Facciolo F, Pompili A, et al: Epigenetic silencing of miR-145-5p contributes to brain metastasis. Oncotarget. 6:35183–35201. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Xu S, Zhang Y, Zhou G and Liu A: Bidirectional negative feedback actions of DNMT3A and miR-145 in regulating autophagy in cardiac fibroblasts and affecting myocardial fibrosis. J Bioenerg Biomembr. 55:341–352. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Agrawal R, Pandey P, Jha P, Dwivedi V, Sarkar C and Kulshreshtha R: Hypoxic signature of microRNAs in glioblastoma: Insights from small RNA deep sequencing. BMC Genomics. 15:6862014. View Article : Google Scholar : PubMed/NCBI | |
|
Xu ZY, Peng J, Shi ZZ, Chen XL, Cheng HZ, Wang H, Wang Y, Wang GP, Jiang W and Peng H: Silencing linc00662 inhibits cell proliferation and colony formation of lung cancer cells via regulating the miR-145-5p-PAFAH1B2 axis. Biochem Cell Biol. 99:330–338. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Abtin M, Nafisi N, Hosseinzadeh A, Kadkhoda S, Omranipour R, Sahebi L, Razipour M, Ghafouri-Fard S and Shakoori A: Inhibition of breast cancer cell growth and migration through siRNA-mediated modulation of circ_0009910/miR-145-5p/MUC1 axis. Noncoding RNA Res. 9:367–375. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
He J, Yan H, Wei S and Chen G: LncRNA ST8SIA6-AS1 promotes cholangiocarcinoma progression by suppressing the miR-145-5p/MAL2 axis. Onco Targets Ther. 14:3209–3223. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou T, Chen S and Mao X: miR-145-5p affects the differentiation of gastric cancer by targeting KLF5 directly. J Cell Physiol. 234:7634–7644. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Ding Y, Cao F, Sun H, Wang Y, Liu S, Wu Y, Cui Q, Mei W and Li F: Exosomes derived from human umbilical cord mesenchymal stromal cells deliver exogenous miR-145-5p to inhibit pancreatic ductal adenocarcinoma progression. Cancer Lett. 442:351–361. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
He S, Yu G, Peng K and Liu S: MicroRNA-145-5p suppresses fascin to inhibit the invasion and migration of cervical carcinoma cells. Mol Med Rep. 22:5282–5292. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou J, Zhang X, Li W and Chen Y: MicroRNA-145-5p regulates the proliferation of epithelial ovarian cancer cells via targeting SMAD4. J Ovarian Res. 13:542020. View Article : Google Scholar : PubMed/NCBI | |
|
Men Y, Zhang L and Ai H: MicroRNA-145-5p over-expression suppresses proliferation, migration and invasion and promotes apoptosis of human endometrial cancer cells by targeting dual specific phosphatase 6. Nan Fang Yi Ke Da Xue Xue Bao. 40:61–66. 2020.(In Chinese). PubMed/NCBI | |
|
Zhu J and Zhang F: Circular RNA VANGL1 knockdown suppressed viability, promoted apoptosis, and increased doxorubicin sensitivity through targeting miR-145-5p to regulate SOX4 in bladder cancer cells. Open Med (Wars). 16:1010–1021. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Le Hars M, Castro-Vega LJ, Rajabi F, Tabatadze D, Romero M, Pinskaya M and Groisman I: Pro-tumorigenic role of lnc-ZNF30-3 as a sponge counteracting miR-145-5p in prostate cancer. Biol Direct. 18:382023. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng Z, Chen Z, Zhong Q, Zhu D, Xie Y, Shangguan W and Xie W: CircPVT1 promotes progression in clear cell renal cell carcinoma by sponging miR-145-5p and regulating TBX15 expression. Cancer Sci. 112:1443–1456. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang T, Yang J, Gong F, Li L and Li A: Long non-coding RNA CASC9 promotes the progression of retinoblastoma via interacting with miR-145-5p. Cell Cycle. 19:2270–2280. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Chen F, Li XH, Liu C, Zhang Y and Wang RJ: Circ-ABCB10 accelerates the malignant progression of oral squamous cell carcinoma by absorbing miRNA-145-5p. Eur Rev Med Pharmacol Sci. 24:681–690. 2020.PubMed/NCBI | |
|
Li H, Pan R, Lu Q, Ren C, Sun J, Wu H, Wen J and Chen H: MicroRNA-145-5p inhibits osteosarcoma cell proliferation by targeting E2F transcription factor 3. Int J Mol Med. 45:1317–1326. 2020.PubMed/NCBI | |
|
Mei LL, Wang WJ, Qiu YT, Xie XF, Bai J and Shi ZZ: miR-145-5p suppresses tumor cell migration, invasion and epithelial to mesenchymal transition by regulating the Sp1/NF-κB signaling pathway in esophageal squamous cell carcinoma. Int J Mol Sci. 18:18332017. View Article : Google Scholar : PubMed/NCBI | |
|
Dong G, Zhang S, Shen S, Sun L, Wang X, Wang H, Wu J, Liu T, Wang C, Wang H, et al: SPATS2, negatively regulated by miR-145-5p, promotes hepatocellular carcinoma progression through regulating cell cycle. Cell Death Dis. 11:8372020. View Article : Google Scholar : PubMed/NCBI | |
|
Wei Q, Liu G, Huang Z, Huang Y, Huang L, Huang Z, Wu X, Wei H and Pu J: LncRNA MEG3 inhibits tumor progression by modulating macrophage phenotypic polarization via miR-145-5p/DAB2 axis in hepatocellular carcinoma. J Hepatocell Carcinoma. 10:1019–1035. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Cheng X, Shen T, Liu P, Fang S, Yang Z, Li Y and Dong J: mir-145-5p is a suppressor of colorectal cancer at early stage, while promotes colorectal cancer metastasis at late stage through regulating AKT signaling evoked EMT-mediated anoikis. BMC Cancer. 22:11512022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu Z, Wu Q, Zhang M, Tong J, Zhong B and Yuan K: Hsa_circ_0016760 exacerbates the malignant development of non-small cell lung cancer by sponging miR-145-5p/FGF5. Oncol Rep. 45:501–512. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, Song Y, Yu B and Yu Y: TNFAIP2 promotes non-small cell lung cancer cells and targeted by miR-145-5p. DNA Cell Biol. 39:1256–1263. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Pei X, Chen SW, Long X, Zhu SQ, Qiu BQ, Lin K, Lu F, Xu JJ, Zhang PF and Wu YB: circMET promotes NSCLC cell proliferation, metastasis, and immune evasion by regulating the miR-145-5p/CXCL3 axis. Aging (Albany NY). 12:13038–13058. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Tang W, Zhang X, Tan W, Gao J, Pan L, Ye X, Chen L and Zheng W: miR-145-5p suppresses breast cancer progression by inhibiting SOX2. J Surg Res. 236:278–287. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Fan S, Chen P and Li S: miR-145-5p inhibits the proliferation, migration, and invasion of esophageal carcinoma cells by targeting ABRACL. Biomed Res Int. 2021:66925442021. View Article : Google Scholar : PubMed/NCBI | |
|
Shi W, Gao Z, Song J and Wang W: Silence of FOXD2-AS1 inhibited the proliferation and invasion of esophagus cells by regulating miR-145-5p/CDK6 axis. Histol Histopathol. 35:1013–1021. 2020.PubMed/NCBI | |
|
Wang S, Wang T and Gu P: microRNA-145-5p inhibits migration, invasion, and metastasis in hepatocellular carcinoma by inhibiting ARF6. Cancer Manag Res. 13:3473–3484. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Su Y, Yu T, Wang Y, Huang X and Wei X: Circular RNA circDNM3OS functions as a miR-145-5p sponge to accelerate cholangiocarcinoma growth and glutamine metabolism by upregulating MORC2. Onco Targets Ther. 14:1117–1129. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Yu X, Ma X, Jia Y, Wu X and Yan Z: Linc-ROR regulates POU5F1 and SOX2 b competitively binding miR-145-5p to affect the proliferation and migration of gastric cancer cells. Cell Transplant. 32:96368972311789022023. View Article : Google Scholar : PubMed/NCBI | |
|
Wang X, Bai X, Yan Z, Guo X and Zhang Y: The lncRNA TUG1 promotes cell growth and migration in colorectal cancer via the TUG1-miR-145-5p-TRPC6 pathway. Biochem Cell Biol. 99:249–260. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Q, Zhou L, Ye X, Tao M and Wu J: miR-145-5p suppresses proliferation, metastasis and EMT of colorectal cancer by targeting CDCA3. Pathol Res Pract. 216:1528722020. View Article : Google Scholar : PubMed/NCBI | |
|
Cao H, Pan G, Tang S, Zhong N, Liu H, Zhou H, Peng Q and Zou Y: miR-145-5p regulates the proliferation, migration and invasion in cervical carcinoma by targeting KLF5. Onco Targets Ther. 13:2369–2376. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Pan Y, Huang Q, Peng X, Yu S and Liu N: Circ_0015756 promotes ovarian cancer progression via the miR-145-5p/PSAT1 axis. Reprod Biol. 22:1007022022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang H, Jiang M, Liu Q, Han Z, Zhao Y and Ji S: miR-145-5p inhibits the proliferation and migration of bladder cancer cells by targeting TAGLN2. Oncol Lett. 16:6355–6360. 2018.PubMed/NCBI | |
|
Tsai YM, Wu KL, Chang YY, Chang WA, Huang YC, Jian SF, Tsai PH, Lin YS, Chong IW, Hung JY and Hsu YL: Loss of miR-145-5p causes ceruloplasmin interference with PHD-Iron axis and HIF-2α stabilization in lung adenocarcinoma-mediated angiogenesis. Int J Mol Sci. 21:50812020. View Article : Google Scholar : PubMed/NCBI | |
|
Guan X and Guan Y: miR-145-5p attenuates paclitaxel resistance and suppresses the progression in drug-resistant breast cancer cell lines. Neoplasma. 67:972–981. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu Y, Ren J, Wu X, Zhang Y, Wang Y, Xu J, Tan Q, Jiang Y and Li Y: lncRNA ENST00000422059 promotes cell proliferation and inhibits cell apoptosis in breast cancer by regulating the miR-145-5p/KLF5 axis. Acta Biochim Biophys Sin (Shanghai). 55:1892–1901. 2023.PubMed/NCBI | |
|
Li Y, Yu J, Zhang Y, Peng C, Song Y and Liu S: Advances in targeted therapy of cholangiocarcinoma. Ann Med. 56:23101962024. View Article : Google Scholar : PubMed/NCBI | |
|
Rawla P and Barsouk A: Epidemiology of gastric cancer: Global trends, risk factors and prevention. Prz Gastroenterol. 14:26–38. 2019.PubMed/NCBI | |
|
Teng F, Zhang JX, Chen Y, Shen XD, Su C, Guo YJ, Wang PH, Shi CC, Lei M, Cao YO and Liu SQ: LncRNA NKX2-1-AS1 promotes tumor progression and angiogenesis via upregulation of SERPINE1 expression and activation of the VEGFR-2 signaling pathway in gastric cancer. Mol Oncol. 15:1234–1255. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Du Q, Zhang M, Gao A, He T and Guo M: Epigenetic silencing ZSCAN23 promotes pancreatic cancer growth by activating Wnt signaling. Cancer Biol Ther. 25:23029242024. View Article : Google Scholar : PubMed/NCBI | |
|
Dobre M, Herlea V, Vlăduţ C, Ciocîrlan M, Balaban VD, Constantinescu G, Diculescu M and Milanesi E: Dysregulation of miRNAs targeting the IGF-1R pathway in pancreatic ductal adenocarcinoma. Cells. 10:18562021. View Article : Google Scholar : PubMed/NCBI | |
|
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Wu L, Zhou WQ, Yuan LN, Li J and Pei ML: Role of miR-145-5p targeting ARK5 in regulating the proliferation and apoptosis of human epithelial ovarian cancer cells. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 43:669–676. 2021.(In Chinese). PubMed/NCBI | |
|
Rohini M, Arumugam B, Vairamani M and Selvamurugan N: Stimulation of ATF3 interaction with Smad4 via TGF-β1 for matrix metalloproteinase 13 gene activation in human breast cancer cells. Int J Biol Macromol. 134:954–961. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Siegel RL, Miller KD, Wagle NS and Jemal A: Cancer statistics, 2023. CA Cancer J Clin. 73:17–48. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Sun G, Tian J, Xiao Y and Zeng Y: Circular RNA circ_0005667 promotes cisplatin resistance of endometrial carcinoma cells by regulating IGF2BP1 through miR-145-5p. Anticancer Drugs. 34:816–826. 2023.PubMed/NCBI | |
|
Du C, Waltzer WC, Wilusz JE, Spaliviero M, Darras F and Romanov V: Circular STAG2 RNA modulates bladder cancer progression via miR-145-5p/TAGLN2 and is considered as a biomarker for recurrence. Cancers (Basel). 16:9782024. View Article : Google Scholar : PubMed/NCBI | |
|
Liu C, Chen J, Cong Y, Chen K, Li H, He Q, Chen L, Song Y and Xing Y: PROX1 drives neuroendocrine plasticity and liver metastases in prostate cancer. Cancer Lett. 597:2170682024. View Article : Google Scholar : PubMed/NCBI | |
|
Ji S, Shi Y, Yang L, Zhang F, Li Y and Xu F: miR-145-5p inhibits neuroendocrine differentiation and tumor growth by regulating the SOX11/MYCN axis in prostate cancer. Front Genet. 13:7906212022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang L, Yu R, Li C, Dang Y, Yi X and Wang L: Circ_0026416 downregulation blocks the development of colorectal cancer through depleting MYO6 expression by enriching miR-545-3p. World J Surg Oncol. 19:2992021. View Article : Google Scholar : PubMed/NCBI | |
|
Armstrong L, Willoughby CE and McKenna DJ: The suppression of the epithelial to mesenchymal transition in prostate cancer through the targeting of MYO6 using MiR-145-5p. Int J Mol Sci. 25:43012024. View Article : Google Scholar : PubMed/NCBI | |
|
Tannir NM, Formiga MN, Penkov K, Kislov N, Vasiliev A, Skare N, Hong W, Dai S, Tang L, Qureshi A, et al: Bempegaldesleukin plus nivolumab versus sunitinib or cabozantinib in previously untreated advanced clear cell renal cell carcinoma: A phase III randomized study (PIVOT-09). J Clin Oncol. 42:2800–2811. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Lv Q, Ma C, Li H, Tan X, Wang G, Zhang Y and Wang P: Circular RNA microarray expression profile and potential function of circ0005875 in clear cell renal cell carcinoma. J Cancer. 11:7146–7156. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Sun J, Cheng W, Guo S, Cai R, Liu G, Wu A and Yin J: A ratiometric SERS strategy for the prediction of cancer cell proportion and guidance of glioma surgical resection. Biosens Bioelectron. 261:1164752024. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Q, Cheng Z, Shi L and Mao G: miR-145-5p inhibits the proliferation of glioma stem cells by targeting translationally controlled tumor protein. J Cancer. 13:1490–1500. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Yang Y, Ji N, Teng QX, Cai CY, Wang JQ, Wu ZX, Lei ZN, Lusvarghi S, Ambudkar SV and Chen ZS: Sitravatinib, a tyrosine kinase inhibitor, inhibits the transport function of ABCG2 and restores sensitivity to chemotherapy-resistant cancer cells in vitro. Front Oncol. 10:7002020. View Article : Google Scholar : PubMed/NCBI | |
|
Hua L, Huang L, Zhang X, Feng H and Shen B: Knockdown of circular RNA CEP128 suppresses proliferation and improves cytotoxic efficacy of temozolomide in glioma cells by regulating miR-145-5p. Neuroreport. 30:1231–1238. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Gregersen PA, Jensen PS, Christensen R, Lohmann D, Racher H, Gallie B and Urbak SF: Retinoblastoma caused by an RB1 variant with unusually low penetrance in a Danish family. Eur J Med Genet. 70:1049562024. View Article : Google Scholar : PubMed/NCBI | |
|
Panchannavar GS and Angadi PV: Tumor budding is a prognostic marker for overall survival and not for lymph node metastasis in oral squamous cell carcinoma-systematic review update and meta-analysis. J Oral Biol Craniofac Res. 14:362–369. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Yu J, Lou Y, Hou M, Ma X and Wang L: Circ_0058063 contributes to oral squamous cell carcinoma development by sponging miR-145-5p and upregulating SERPINE1. J Oral Pathol Med. 51:630–637. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Coca-Pelaz A, Shah JP, Hernandez-Prera JC, Ghossein RA, Rodrigo JP, Hartl DM, Olsen KD, Shaha AR, Zafereo M, Suarez C, et al: Papillary thyroid cancer-aggressive variants and impact on management: A narrative review. Adv Ther. 37:3112–3128. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Feng J, Zhou Q, Yi H, Ma S, Li D, Xu Y, Wang J and Yin S: A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3. Cell Death Dis. 10:4332019. View Article : Google Scholar : PubMed/NCBI | |
|
Yang C and Hardy P: The multifunctional nature of the MicroRNA/AKT3 regulatory axis in human cancers. Cells. 12:25942023. View Article : Google Scholar : PubMed/NCBI | |
|
Liang H, Cui M, Tu J and Chen X: Advancements in osteosarcoma management: Integrating immune microenvironment insights with immunotherapeutic strategies. Front Cell Dev Biol. 12:13943392024. View Article : Google Scholar : PubMed/NCBI | |
|
Cao C and Shu X: Suppression of circ_0008932 inhibits tumor growth and metastasis in osteosarcoma by targeting miR-145-5p. Exp Ther Med. 22:11062021. View Article : Google Scholar : PubMed/NCBI | |
|
Xie W, Ma F, Dou L, Chang W, Yuan D, Zhang Z and Zhang Y: Allicin affects immunoreactivity of osteosarcoma cells through lncRNA CBR3-AS1. Heliyon. 10:e319712024. View Article : Google Scholar : PubMed/NCBI | |
|
D'Alò F, Bellesi S, Maiolo E, Alma E, Bellisario F, Malafronte R, Viscovo M, Campana F and Hohaus S: Novel targets and advanced therapies in diffuse large B cell lymphomas. Cancers (Basel). 16:22432024. View Article : Google Scholar : PubMed/NCBI | |
|
Gao Y and Ding X: miR-145-5p exerts anti-tumor effects in diffuse large B-cell lymphoma by regulating S1PR1/STAT3/AKT pathway. Leuk Lymphoma. 62:1884–1891. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Guo QQ, Ma SZ, Zhao Y, Beeraka NM, Gu H, Zheng YF, Zhao RW, Li ST, Nikolenko VN, Bulygin KV, et al: Association of definitive radiotherapy for esophageal cancer and the incidence of secondary head and neck cancers: A SEER population-based study. World J Oncol. 15:598–611. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Niu Y, Zhang J, Tong Y, Li J and Liu B: miR-145-5p restrained cell growth, invasion, migration and tumorigenesis via modulating RHBDD1 in colorectal cancer via the EGFR-associated signaling pathway. Int J Biochem Cell Biol. 117:1056412019. View Article : Google Scholar : PubMed/NCBI | |
|
Rajarajan D, Kaur B, Penta D, Natesh J and Meeran SM: miR-145-5p as a predictive biomarker for breast cancer stemness by computational clinical investigation. Comput Biol Med. 135:1046012021. View Article : Google Scholar : PubMed/NCBI | |
|
García-García F, Salinas-Vera YM, García-Vázquez R, Marchat LA, Rodríguez-Cuevas S, López-González JS, Carlos-Reyes Á, Ramos-Payán R, Aguilar-Medina M, Pérez-Plasencia C, et al: miR-145-5p is associated with pathological complete response to neoadjuvant chemotherapy and impairs cell proliferation by targeting TGFβR2 in breast cancer. Oncol Rep. 41:3527–3534. 2019.PubMed/NCBI | |
|
Bagheri M, Khansarinejad B, Mosayebi G, Moradabadi A and Mondanizadeh M: Diagnostic value of plasma miR-145 and miR-185 as targeting of the APRIL oncogene in the B-cell chronic lymphocytic leukemia. Asian Pac J Cancer Prev. 22:111–117. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Ta WW, Sun PF, Meng YF and Zhao CZ: Diagnostic and prognostic significance of serum miR-145-5p expression in glioblastoma. Int J Clin Exp Pathol. 12:2536–2543. 2019.PubMed/NCBI | |
|
Hang W, Feng Y, Sang Z, Yang Y, Zhu Y, Huang Q and Xi X: Downregulation of miR-145-5p in cancer cells and their derived exosomes may contribute to the development of ovarian cancer by targeting CT. Int J Mol Med. 43:256–266. 2019.PubMed/NCBI | |
|
Aftab M, Poojary SS, Seshan V, Kumar S, Agarwal P, Tandon S, Zutshi V and Das BC: Urine miRNA signature as a potential non-invasive diagnostic and prognostic biomarker in cervical cancer. Sci Rep. 11:103232021. View Article : Google Scholar : PubMed/NCBI | |
|
Bahreini F, Saidijam M, Mousivand Z, Najafi R and Afshar S: Assessment of lncRNA DANCR, miR-145-5p and NRAS axis as biomarkers for the diagnosis of colorectal cancer. Mol Biol Rep. 48:3541–3547. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Bahreini F, Saidijam M, Afshar S, Mousivand Z and Najafi R: The effect of miR-145-5p, DANCR and NRAS expression levels on the survival rate of colorectal cancer patients. Asian Pac J Cancer Prev. 22:4043–4049. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Wen J, Luo K, Liu H, Liu S, Lin G, Hu Y, Zhang X, Wang G, Chen Y, Chen Z, et al: MiRNA expression analysis of pretreatment biopsies predicts the pathological response of esophageal squamous cell carcinomas to neoadjuvant chemoradiotherapy. Ann Surg. 263:942–948. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Tuo Z, Liang L and Zhou R: LINC00852 is associated with poor prognosis in non-small cell lung cancer patients and its inhibition suppresses cancer cell proliferation and chemoresistance via the hsa-miR-145-5p/KLF4 axis. J Gene Med. 23:e33842021. View Article : Google Scholar : PubMed/NCBI | |
|
Xie L, Cui G and Li T: Long Noncoding RNA CBR3-AS1 promotes stem-like properties and oxaliplatin resistance of colorectal cancer by sponging miR-145-5p. J Oncol. 2022:22602112022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou F, Ding W, Mao Q, Jiang X, Chen J, Zhao X, Xu W, Huang J, Zhong L and Sun X: The regulation of hsacirc_004413 promotes proliferation and drug resistance of gastric cancer cells by acting as a competing endogenous RNA for miR-145-5p. PeerJ. 10:e126292022. View Article : Google Scholar : PubMed/NCBI | |
|
Wang W, Ding B, Lou W and Lin S: Promoter hypomethylation and miR-145-5p downregulation- mediated HDAC11 overexpression promotes sorafenib resistance and metastasis of hepatocellular carcinoma cells. Front Cell Dev Biol. 8:7242020. View Article : Google Scholar : PubMed/NCBI | |
|
Khalighfard S, Kalhori MR, Amiriani T, Poorkhani A, Khori V, Esmati E, Lashkari M, Najafi A and Alizadeh AM: A systematic approach introduced novel targets in rectal cancer by considering miRNA/mRNA interactions in response to radiotherapy. Cancer Biomark. 33:97–110. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Tian J, Wang N, Wang C, Wu DP, Wang CH, Ding XJ and Wang YK: Hsa_circ_0000392 affects the radiation sensitivity of cervical cancer by targeting the miR-145-5p/CRKL/MAPK pathway. Zhonghua Zhong Liu Za Zhi. 45:879–891. 2023.(In Chinese). PubMed/NCBI | |
|
Parayath NN, Gandham SK and Amiji MM: Tumor-targeted miRNA nanomedicine for overcoming challenges in immunity and therapeutic resistance. Nanomedicine (Lond). 17:1355–1373. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Luna C, Parker M, Challa P and Gonzalez P: Long-term decrease of intraocular pressure in rats by viral delivery of miR-146a. Transl Vis Sci Technol. 10:142021. View Article : Google Scholar : PubMed/NCBI | |
|
Sun F, Chen H, Dai X, Hou Y, Li J, Zhang Y, Huang L, Guo B and Yang D: Liposome-lentivirus for miRNA therapy with molecular mechanism study. J Nanobiotechnology. 22:3292024. View Article : Google Scholar : PubMed/NCBI | |
|
Xu J, Liu W, Fan F, Zhang B, Sun C and Hu Y: Advances in nano-immunotherapy for hematological malignancies. Exp Hematol Oncol. 13:572024. View Article : Google Scholar : PubMed/NCBI | |
|
Fan B, Yang X, Li X, Lv S, Zhang H, Sun J, Li L, Wang L, Qu B, Peng X and Zhang R: Photoacoustic-imaging-guided therapy of functionalized melanin nanoparticles: Combination of photothermal ablation and gene therapy against laryngeal squamous cell carcinoma. Nanoscale. 11:6285–6296. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Dai J, Cheng Y, Wu J, Wang Q, Wang W, Yang J, Zhao Z, Lou X, Xia F, Wang S and Tang BZ: Modular peptide probe for Pre/Intra/Postoperative therapeutic to reduce recurrence in ovarian cancer. ACS Nano. 14:14698–14714. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang X, Li F, Zhang J, Guo L, Shang M, Sun X, Xiao S, Shi D, Meng D, Zhao Y, et al: A combination of PD-L1-targeted IL-15 mRNA nanotherapy and ultrasound-targeted microbubble destruction for tumor immunotherapy. J Control Release. 367:45–60. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Ren L, Wang L, Yi X, Tan Y, Yi L, He J and Li D: Ultrasound microbubble-stimulated miR-145-5p inhibits malignant behaviors of breast cancer cells by targeting ACTG1. Ultrasound Q. 40:136–143. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang T, Qiao Y, Ruan W, Zhang D, Yang Q, Wang G, Chen Q, Zhu F, Yin J, Zou Y, et al: Cation-Free siRNA micelles as effective drug delivery platform and potent RNAi nanomedicines for glioblastoma therapy. Adv Mater. 33:e21047792021. View Article : Google Scholar : PubMed/NCBI | |
|
Howe SJ, Mansour MR, Schwarzwaelder K, Bartholomae C, Hubank M, Kempski H, Brugman MH, Pike-Overzet K, Chatters SJ, de Ridder D, et al: Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest. 118:3143–3150. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Jusoh AR, Mohan SV, Ping TL, Din TADAAB, Haron J, Romli RC, Jaafar H, Nafi SN, Salwani TI and Yahya MM: Plasma circulating mirnas profiling for identification of potential breast cancer early detection biomarkers. Asian Pac J Cancer Prev. 22:1375–1381. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
García-Magallanes N, Beltran-Ontiveros SA, Leal-León EA, Luque-Ortega F, Romero-Quintana JG, Osuna-Ramirez I, Barbosa-Jasso M and Arámbula-Meraz E: Underexpression of circulating miR-145-5p and miR-133a-3p are associated with breast cancer and immunohistochemical markers. J Cancer Res Ther. 16:1223–1228. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Pigati L, Yaddanapudi SC, Iyengar R, Kim DJ, Hearn SA, Danforth D, Hastings ML and Duelli DM: Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS One. 5:e135152010. View Article : Google Scholar : PubMed/NCBI | |
|
Hernandez BJ, Strain M, Suarez MF, Stamer WD, Ashley-Koch A, Liu Y, Klingeborn M and Rickman CB: Small extracellular vesicle-associated MiRNAs in polarized retinal pigmented epithelium. Invest Ophthalmol Vis Sci. 65:572024. View Article : Google Scholar : PubMed/NCBI | |
|
Guo Y, Han Y, Zhang J, Zhou Y, Wei M and Yu L: Identification and experimental validation of prognostic miRNA signature and ferroptosis-related key genes in cervical squamous cell carcinoma. Cancer Med. 13:e704152024. View Article : Google Scholar : PubMed/NCBI |
